Home » Topics » Disease categories and therapies » Immune

Immune
RSS

LeIF adjuvant enhances therapeutic efficacy of leishmaniasis vaccine in humans

April 9, 1999

Stanford Rook establishes strategic research collaboration with Genesis

April 8, 1999

PowderJect presents positive data using PowderJect DNA vaccine

April 8, 1999

Aquila reveals new product in pipeline: CD1-TB

April 5, 1999

Merck & Co. presents new macrolide immunosuppressants

April 1, 1999

Aquila initiates phase IIb testing of Quilimmune-P

April 1, 1999

New patent expands protection for BioTransplant's AlloMune and XenoMune systems

March 23, 1999

Collaboration between Wyeth and Aviron for FluMist effective immediately

March 23, 1999

German launch announced for Novartis immunosuppressant

March 22, 1999

Novel tacrolimus (FK-506) prodrug expected to have superior therapeutic activity

March 22, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 31, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 2, 2026.
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...
AND-017 increases RBC and hemoglobin in sickle cell disease
BioWorld Science
Sickle cell disease (SCD) is an inherited hemoglobinopathy caused by a mutation in the gene encoding β-globin that results in hemoglobin S polymerization, red...